Paragon Capital Management (Utah)’s Regeneron Pharmaceuticals REGN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$1.16M	Sell	2,206 -4	-0.2%	-$2.1K	0.88%	45
2025 Q1	$1.4M	Buy	2,210 +446	+25%	+$283K	1.13%	31
2024 Q4	$1.26M	Buy	+1,764	New	+$1.26M	0.98%	42
2022 Q1	–	Sell	-1,148	Closed	-$725K	–	78
2021 Q4	$725K	Buy	+1,148	New	+$725K	0.62%	51